Proteros Biostructures

Private

GermanyHealthcare & Life Scienceshttps://www.proteros.com/

Last Round

Private Equity

Jan 9, 2023

Momentum

Quiet

No recent growth signals

Company Overview

Proteros Biostructures GmbH is a contract research organization that provides structure-based early-stage drug discovery services for the pharmaceutical and biotech industries.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROstructure-based drug discoverydrug discovery servicesstructural biologyX-ray crystallographyCryo-EMprotein scienceshit-to-lead servicesundruggable targetslead optimizationbiophysical screeningprotein productionhigh-throughput screeningHTSAI-enabled drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Proteros Biostructures Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Proteros Biostructures Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Private Equity	Jan 9, 2023
VC Round	Aug 6, 2012
VC Round	Aug 22, 2007

View all Funding Rounds

Key People

Founding team and executive leadership

Joachim Scheuenpflug

Chief Financial Officer & Chief Operating Officer

Executive Team

Proteros Biostructures Investors

Notable investors and investment history

Investor	Rounds
Inflexion Private Equity	Private Equity
BayBG Bayerische Beteiligungsgesellschaft	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 1, 2026
Monthly visitors grew 89% MoM, reaching 8.3K.
Dec 9, 2025
Monthly visitors increased 68% MoM, reaching 4.4K.

View all signals

Proteros Biostructures Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Proteros Biostructures Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Proteros Biostructures's valuation, stock price, and market status.

Firmographic Details

HeadquartersGermany

Employee Range160

Year Founded1998

Last FundingJan 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.